Sakar Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectables (SVP) in ampoules and vials & lyophilized injections. The Company's oncology products include oral solid dosage (tablet & capsule), liquid injection, lyophilized injection, active pharmaceutical ingredient (API), CDMO products and CRAMs. It has a presence across the regions of Africa (Anglo & Francophone), SEASIA, CIS, Latin & Central America and in Europe. It operates in over 50 countries globally and has approximately 292 registered products. It exports to Southeast Asia, Asia, Africa-Anglo & Francophone, MENA, America, covering around 38 countries with more than 250 brands registered.As of 9 Jun 2026, Sakar Healthcare share price is ₹794.35. The stock opened at ₹783.95, compared to its previous close of ₹767.60. During today's trading session, Sakar Healthcare share price moved in the range of ₹773.55 to ₹808.80, with an average price of ₹791.17 for the day. Looking at its last 52-week, the stock has touched a low of ₹773.55 and a high of ₹808.80. On the performance front, Sakar Healthcare share price has increased by 110.39% over the last six months and is up 141.16% on a year-on-year basis.
The market capitalization of Sakar Healthcare is ₹1,708 Crs, with a P/E ratio of 56.4 and a dividend yield of 0.00%.